Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM TrialMarcello Tiseo, Andrea Ardizzoni, Andrea Camerini et al.|Journal of Clinical Oncology|2017Cited by 186
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Anna Maria Cremonini, Alicia Tosoni et al.|World Neurosurgery|2018Cited by 59
Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM TrialMarcello Tiseo, Andrea Ardizzoni, Luca Boni et al.|Clinical Lung Cancer|2014Cited by 19
A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung CancerLuigi Tarantini, Carmine Pinto, Giuseppina Gallucci et al.|Cancers|2025Cited by 4
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysisPatrizia Ciammella, Marcello Tiseo, Salvatore Cozzi et al.|Frontiers in Oncology|2024Cited by 3